Today's Stock Price Targets and Analyst Ratings

Company	Action	Brokerage	Analyst	Current Price	Price Target	Rating
AAPL Apple	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access to unlock brokerage rankings	Barton Crockett Subscribe to MarketBeat All Access to unlock analyst rankings	$329.44 -2.6%	$303.00	Neutral
AAPL Apple	Reiterated by	KeyCorp Subscribe to MarketBeat All Access to unlock brokerage rankings	Brandon Nispel Subscribe to MarketBeat All Access to unlock analyst rankings	$329.44 -2.6%	$250.00	Underweight
AAPL Apple	Target Raised by	DA Davidson Subscribe to MarketBeat All Access to unlock brokerage rankings	Gil Luria Subscribe to MarketBeat All Access to unlock analyst rankings	$329.44 -2.6%	$270.00 ➝ $295.00	Neutral
AAPL Apple	Target Raised by	Argus Subscribe to MarketBeat All Access to unlock brokerage rankings	Jim Kelleher Subscribe to MarketBeat All Access to unlock analyst rankings	$329.44 -2.6%	$375.00 ➝ $400.00	Buy
AAPL Apple	Target Raised by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Tim Long Subscribe to MarketBeat All Access to unlock analyst rankings	$329.44 -2.6%	$245.00 ➝ $261.00	Underweight
AAPL Apple	Target Lowered by	TD Cowen Subscribe to MarketBeat All Access to unlock brokerage rankings	Krish Sankar Subscribe to MarketBeat All Access to unlock analyst rankings	$329.44 -2.6%	$400.00 ➝ $390.00	Buy
AAPL Apple	Target Set by	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	David Vogt Subscribe to MarketBeat All Access to unlock analyst rankings	$329.44 -2.6%	$370.00
AAPL Apple	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access to unlock brokerage rankings	Erik Woodring Subscribe to MarketBeat All Access to unlock analyst rankings	$329.44 -2.6%	$355.00 ➝ $350.00	Overweight
AAPL Apple	Target Set by	Melius Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Ben Reitzes Subscribe to MarketBeat All Access to unlock analyst rankings	$329.44 -2.6%	$370.00
AAPL Apple	Reiterated by	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings		$329.44 -2.6%		Neutral
The 401k Email 70 Million Investors Might Delete (Ad) An email announcing a new 401k investment option is headed to roughly 70 million inboxes. Most recipients will delete it without a second look. Larry Benedict says that would be a mistake. He calls this the decade's biggest opportunity and is naming the one ticker to watch before it arrives. Watch his free breakdown now. Watch the free breakdown before this 401k change arrives
AAPL Apple	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access to unlock brokerage rankings		$329.44 -2.6%		Market Perform
AAPL Apple	Target Set by	Robert W. Baird Subscribe to MarketBeat All Access to unlock brokerage rankings	William Power Subscribe to MarketBeat All Access to unlock analyst rankings	$329.44 -2.6%	$330.00 ➝ $340.00	Outperform
AAPL Apple	Target Set by	Guggenheim Subscribe to MarketBeat All Access to unlock brokerage rankings		$329.44 -2.6%	$400.00
ABNB Airbnb	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Josh Beck Subscribe to MarketBeat All Access to unlock analyst rankings	$168.40 -1.6%		Outperform
ACG ACG Acquisition	Reiterated by	Canaccord Genuity Group Subscribe to MarketBeat All Access to unlock brokerage rankings		GBX 1,687.90 +18.9%	GBX 2,295	Buy
ACG ACG Acquisition	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access to unlock brokerage rankings		GBX 1,687.90 +18.9%	GBX 2,300	Buy
ADDYY Adidas	Downgraded by	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings		$94.54 -1.8%		Neutral ➝ Sell
ADEA Adeia	Target Lowered by	Rosenblatt Securities Subscribe to MarketBeat All Access to unlock brokerage rankings	Kevin Cassidy Subscribe to MarketBeat All Access to unlock analyst rankings	$17.01 -17.7%	$40.00 ➝ $35.00	Buy
AEIS Advanced Energy Industries	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access to unlock brokerage rankings	Joe Quatrochi Subscribe to MarketBeat All Access to unlock analyst rankings	$241.95 +11.4%	$310.00	Overweight
AEIS Advanced Energy Industries	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access to unlock brokerage rankings	Robert Mason Subscribe to MarketBeat All Access to unlock analyst rankings	$241.95 +11.4%	$410.00 ➝ $330.00	Outperform
AEP American Electric Power	Target Set by	Jefferies Financial Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Julien Dumoulin-Smith Subscribe to MarketBeat All Access to unlock analyst rankings	$129.90 -0.3%	$153.00
AFYA Afya	Upgraded by	Citigroup Subscribe to MarketBeat All Access to unlock brokerage rankings	Leandro Bastos Subscribe to MarketBeat All Access to unlock analyst rankings	$10.50 -1.3%	$16.00 ➝ $12.00	Neutral ➝ Buy
AIRO AIRO Group	Initiated by	Roth Capital Subscribe to MarketBeat All Access to unlock brokerage rankings		$5.57 +7.5%	$16.00	Buy
AJG Arthur J. Gallagher & Co.	Downgraded by	BMO Capital Markets Subscribe to MarketBeat All Access to unlock brokerage rankings	Michael Zaremski Subscribe to MarketBeat All Access to unlock analyst rankings	$277.28 -0.6%	$295.00	Outperform ➝ Market Perform
AN AutoNation	Target Lowered by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	John Babcock Subscribe to MarketBeat All Access to unlock analyst rankings	$183.87 -1.1%	$230.00 ➝ $220.00	Overweight
AON AON	Upgraded by	BMO Capital Markets Subscribe to MarketBeat All Access to unlock brokerage rankings	Michael Zaremski Subscribe to MarketBeat All Access to unlock analyst rankings	$332.35 -0.3%	$319.00 ➝ $380.00	Market Perform ➝ Outperform
ARE Alexandria Real Estate Equities	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access to unlock brokerage rankings	Michael Carroll Subscribe to MarketBeat All Access to unlock analyst rankings	$41.88 -1.6%	$51.00 ➝ $47.00	Sector Perform
ASB Associated Banc	Target Raised by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Jared Shaw Subscribe to MarketBeat All Access to unlock analyst rankings	$31.36 +0.7%	$35.00 ➝ $37.00	Overweight
AXSM Axsome Therapeutics	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access to unlock brokerage rankings	Joel Beatty Subscribe to MarketBeat All Access to unlock analyst rankings	$140.31 +3.2%	$246.00 ➝ $220.00	Outperform
AXSM Axsome Therapeutics	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access to unlock brokerage rankings	Leonid Timashev Subscribe to MarketBeat All Access to unlock analyst rankings	$140.31 +3.2%	$295.00 ➝ $273.00	Outperform
AXSM Axsome Therapeutics	Target Lowered by	Guggenheim Subscribe to MarketBeat All Access to unlock brokerage rankings	Yatin Suneja Subscribe to MarketBeat All Access to unlock analyst rankings	$140.31 +3.2%	$275.00 ➝ $250.00	Buy
AXSM Axsome Therapeutics	Reiterated by	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Ashwani Verma Subscribe to MarketBeat All Access to unlock analyst rankings	$140.31 +3.2%	$239.00	Buy
AXSM Axsome Therapeutics	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access to unlock brokerage rankings	Benjamin Burnett Subscribe to MarketBeat All Access to unlock analyst rankings	$140.31 +3.2%		Outperform
BE Bloom Energy	Upgraded by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Christine Cho Subscribe to MarketBeat All Access to unlock analyst rankings	$217.03 +10.6%	$316.00 ➝ $289.00	Equal Weight ➝ Overweight
BE Bloom Energy	Downgraded by	BMO Capital Markets Subscribe to MarketBeat All Access to unlock brokerage rankings	Ameet Thakkar Subscribe to MarketBeat All Access to unlock analyst rankings	$217.03 +10.6%		Outperform ➝ Market Perform
BLZE Backblaze	Reiterated by	Citigroup Subscribe to MarketBeat All Access to unlock brokerage rankings		$8.11 +9.5%		Market Outperform
BLZE Backblaze	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	Mike Cikos Subscribe to MarketBeat All Access to unlock analyst rankings	$8.11 +9.5%	$23.00 ➝ $15.00	Buy
BMRN BioMarin Pharmaceutical	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access to unlock brokerage rankings	Luca Issi Subscribe to MarketBeat All Access to unlock analyst rankings	$54.39 -5.3%	$62.00 ➝ $60.00	Sector Perform
BMRN BioMarin Pharmaceutical	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access to unlock brokerage rankings	Paul Matteis Subscribe to MarketBeat All Access to unlock analyst rankings	$54.39 -5.3%	$70.00 ➝ $66.00	Hold
BMRN BioMarin Pharmaceutical	Reiterated by	Oppenheimer Subscribe to MarketBeat All Access to unlock brokerage rankings	Leland Gershell Subscribe to MarketBeat All Access to unlock analyst rankings	$54.39 -5.3%	$94.00	Outperform
U.S. Army Advances 75-Year Rare Earth Deal With Nasdaq Firm (Ad) The Pentagon is moving to cut US dependence on Chinese rare earth metals, and a Nasdaq-listed company just signed a term sheet for a potential 75-year agreement with the US Army. The proposed deal would let the company build and operate a rare earth processing facility on an active military base, with the Army getting first right to production. New Pentagon restrictions on Chinese-origin rare earth magnets take effect January 1, 2027. The company's mine-to-magnet platform covers feedstock agreements, processing, metallization, and downstream manufacturing, with commercial output targeted for 2027. Read the full breakdown on this rare earth opportunity now
BSRR Sierra Bancorp	Target Raised by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access to unlock brokerage rankings	Wood Lay Subscribe to MarketBeat All Access to unlock analyst rankings	$42.41 -0.6%	$42.00 ➝ $44.00	Market Perform
BTSG BrightSpring Health Services	Target Raised by	Guggenheim Subscribe to MarketBeat All Access to unlock brokerage rankings	Jason Cassorla Subscribe to MarketBeat All Access to unlock analyst rankings	$69.10 +4.3%	$81.00 ➝ $84.00	Buy
BVS Bioventus	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Caitlin Cronin Subscribe to MarketBeat All Access to unlock analyst rankings	$10.88 -17.3%	$19.00 ➝ $18.00	Buy
CHD Church & Dwight	Reiterated by	TD Cowen Subscribe to MarketBeat All Access to unlock brokerage rankings	Robert Moskow Subscribe to MarketBeat All Access to unlock analyst rankings	$109.46 -0.9%	$115.00	Hold
CHD Church & Dwight	Target Raised by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Lauren Lieberman Subscribe to MarketBeat All Access to unlock analyst rankings	$109.46 -0.9%	$83.00 ➝ $89.00	Underweight
CHH Choice Hotels International	Target Raised by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Anthony Powell Subscribe to MarketBeat All Access to unlock analyst rankings	$119.55 +0.8%	$103.00 ➝ $107.00	Underweight
CHKP Check Point Software Technologies	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access to unlock brokerage rankings	Matthew Hedberg Subscribe to MarketBeat All Access to unlock analyst rankings	$139.86 -1.2%	$135.00 ➝ $140.00	Sector Perform
CHKP Check Point Software Technologies	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access to unlock brokerage rankings	Shrenik Kothari Subscribe to MarketBeat All Access to unlock analyst rankings	$139.86 -1.2%	$175.00 ➝ $170.00	Outperform
CHKP Check Point Software Technologies	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access to unlock brokerage rankings	Jonathan Ruykhaver Subscribe to MarketBeat All Access to unlock analyst rankings	$139.86 -1.2%	$150.00	Neutral
CHKP Check Point Software Technologies	Target Raised by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Saket Kalia Subscribe to MarketBeat All Access to unlock analyst rankings	$139.86 -1.2%	$140.00 ➝ $155.00	Equal Weight
CHKP Check Point Software Technologies	Target Raised by	Susquehanna Subscribe to MarketBeat All Access to unlock brokerage rankings	Shyam Patil Subscribe to MarketBeat All Access to unlock analyst rankings	$139.86 -1.2%	$150.00 ➝ $165.00	Positive
CHKP Check Point Software Technologies	Reiterated by	Scotiabank Subscribe to MarketBeat All Access to unlock brokerage rankings	Patrick Colville Subscribe to MarketBeat All Access to unlock analyst rankings	$139.86 -1.2%	$175.00	Sector Outperform
CHKP Check Point Software Technologies	Target Set by	Wells Fargo & Company Subscribe to MarketBeat All Access to unlock brokerage rankings	Richard Poland Subscribe to MarketBeat All Access to unlock analyst rankings	$139.86 -1.2%	$135.00
CHKP Check Point Software Technologies	Reiterated by	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings		$139.86 -1.2%		Neutral
CHRY Chrysalis Investments	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access to unlock brokerage rankings		GBX 67.20 +0.9%		Buy
CIFR Cipher Mining	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access to unlock brokerage rankings	Eric Luebchow Subscribe to MarketBeat All Access to unlock analyst rankings	$7.72 +12.5%	$15.00	Overweight
CIFR Cipher Mining	Reiterated by	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Ryan Gravett Subscribe to MarketBeat All Access to unlock analyst rankings	$7.72 +12.5%	$18.00	Overweight
CIFR Cipher Mining	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	John Todaro Subscribe to MarketBeat All Access to unlock analyst rankings	$7.72 +12.5%	$25.00 ➝ $15.00	Buy
CIFR Cipher Mining	Target Lowered by	Rosenblatt Securities Subscribe to MarketBeat All Access to unlock brokerage rankings	Chris Brendler Subscribe to MarketBeat All Access to unlock analyst rankings	$7.72 +12.5%	$30.00 ➝ $19.00	Buy
CIFR Cipher Mining	Target Lowered by	Cantor Fitzgerald Subscribe to MarketBeat All Access to unlock brokerage rankings	Brett Knoblauch Subscribe to MarketBeat All Access to unlock analyst rankings	$7.72 +12.5%	$19.00 ➝ $15.00	Overweight
CL Colgate-Palmolive	Target Raised by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Lauren Lieberman Subscribe to MarketBeat All Access to unlock analyst rankings	$95.83 -1.6%	$87.00 ➝ $95.00	Equal Weight
CLX Clorox	Reiterated by	The Goldman Sachs Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Bonnie Herzog Subscribe to MarketBeat All Access to unlock analyst rankings	$92.92 +3.4%	$74.00	Sell
CLX Clorox	Target Set by	Wells Fargo & Company Subscribe to MarketBeat All Access to unlock brokerage rankings	Chris Carey Subscribe to MarketBeat All Access to unlock analyst rankings	$92.92 +3.4%	$85.00 ➝ $90.00	Equal Weight
CMPS Compass Pathways	Reiterated by	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Thomas Shrader Subscribe to MarketBeat All Access to unlock analyst rankings	$9.09 +8.1%	$25.00	Buy
CNA Centrica	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access to unlock brokerage rankings		GBX 151.85 +1.3%	GBX 200	Buy
CNI Canadian National Railway	Target Raised by	Susquehanna Subscribe to MarketBeat All Access to unlock brokerage rankings	Bascome Majors Subscribe to MarketBeat All Access to unlock analyst rankings	$126.27 -0.4%	$130.00 ➝ $140.00	Neutral
COIN Coinbase Global	Target Lowered by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access to unlock brokerage rankings	Stephen Glagola Subscribe to MarketBeat All Access to unlock analyst rankings	$148.45 +7.7%	$237.00 ➝ $221.00	Outperform
COLB Columbia Banking System	Target Raised by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Jared Shaw Subscribe to MarketBeat All Access to unlock analyst rankings	$31.29 +0.1%	$32.00 ➝ $34.00	Equal Weight
CP Canadian Pacific Kansas City	Target Raised by	Susquehanna Subscribe to MarketBeat All Access to unlock brokerage rankings	Bascome Majors Subscribe to MarketBeat All Access to unlock analyst rankings	$91.32 -0.2%	$98.00 ➝ $105.00	Positive
CRSP CRISPR Therapeutics	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	Gil Blum Subscribe to MarketBeat All Access to unlock analyst rankings	$51.09 +2.2%	$82.00	Buy
CRSP CRISPR Therapeutics	Reiterated by	Citigroup Subscribe to MarketBeat All Access to unlock brokerage rankings	Yigal Nochomovitz Subscribe to MarketBeat All Access to unlock analyst rankings	$51.09 +2.2%		Market Outperform
CVEO Civeo	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access to unlock brokerage rankings	Stephen Gengaro Subscribe to MarketBeat All Access to unlock analyst rankings	$36.90 +2.2%	$37.00 ➝ $42.00	Buy
CVX Chevron	Downgraded by	DZ Bank Subscribe to MarketBeat All Access to unlock brokerage rankings		$226.12 -0.7%	$240.00	Buy ➝ Hold
CYH Community Health Systems	Target Lowered by	Wells Fargo & Company Subscribe to MarketBeat All Access to unlock brokerage rankings	Stephen Baxter Subscribe to MarketBeat All Access to unlock analyst rankings	$2.17 +3.1%	$2.00 ➝ $1.00	Underweight
DBX Dropbox	Initiated by	Stephens Subscribe to MarketBeat All Access to unlock brokerage rankings	Brett Huff Subscribe to MarketBeat All Access to unlock analyst rankings	$35.40 -0.7%	$39.00	Equal Weight
DHI D.R. Horton	Downgraded by	Raymond James Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Buck Horne Subscribe to MarketBeat All Access to unlock analyst rankings	$146.69 -4.1%		Market Perform ➝ Underperform
DOTD dotdigital Group	Target Lowered by	Canaccord Genuity Group Subscribe to MarketBeat All Access to unlock brokerage rankings		GBX 53 +0.2%	GBX 135 ➝ GBX 130	Buy
DRUG Bright Minds Biosciences	Target Lowered by	Robert W. Baird Subscribe to MarketBeat All Access to unlock brokerage rankings	Joel Beatty Subscribe to MarketBeat All Access to unlock analyst rankings	$25.27 -3.5%	$126.00 ➝ $107.00	Outperform
EBC Eastern Bankshares	Target Raised by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Jared Shaw Subscribe to MarketBeat All Access to unlock analyst rankings	$23.10 +0.8%	$23.00 ➝ $24.00	Equal Weight
EDV Endeavour Mining	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access to unlock brokerage rankings		GBX 3,628 -2.8%	GBX 5,700	Buy
EL Estee Lauder Companies	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access to unlock brokerage rankings	Christopher Carey Subscribe to MarketBeat All Access to unlock analyst rankings	$106.64 +1.8%	$95.00 ➝ $110.00	Equal Weight
EL Estee Lauder Companies	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access to unlock brokerage rankings	Nik Modi Subscribe to MarketBeat All Access to unlock analyst rankings	$106.64 +1.8%	$120.00 ➝ $126.00	Outperform
ENSG The Ensign Group	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access to unlock brokerage rankings	Ben Hendrix Subscribe to MarketBeat All Access to unlock analyst rankings	$183.06 +2.2%	$228.00 ➝ $239.00	Outperform
ENT Entain	Target Lowered by	Berenberg Bank Subscribe to MarketBeat All Access to unlock brokerage rankings		GBX 479 -0.3%	GBX 1,090 ➝ GBX 1,080	Buy
EPRT Essential Properties Realty Trust	Target Lowered by	Cantor Fitzgerald Subscribe to MarketBeat All Access to unlock brokerage rankings	Jay Kornreich Subscribe to MarketBeat All Access to unlock analyst rankings	$27.48 +0.4%	$37.00 ➝ $31.00	Overweight
ETR Entergy	Reiterated by	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Alex Kania Subscribe to MarketBeat All Access to unlock analyst rankings	$109.52 -0.3%	$117.00 ➝ $124.00	Buy
EVER EverQuote	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	Mayank Tandon Subscribe to MarketBeat All Access to unlock analyst rankings	$27.88 +14.9%	$30.00 ➝ $35.00	Buy
EVER EverQuote	Reiterated by	Citigroup Subscribe to MarketBeat All Access to unlock brokerage rankings		$27.88 +14.9%		Buy
EVER EverQuote	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Michael Grahamham Subscribe to MarketBeat All Access to unlock analyst rankings	$27.88 +14.9%	$28.00 ➝ $32.00	Buy
EVGO EVgo	Downgraded by	Cantor Fitzgerald Subscribe to MarketBeat All Access to unlock brokerage rankings	Andres Sheppard Subscribe to MarketBeat All Access to unlock analyst rankings	$1.84 -0.8%	$3.00 ➝ $2.00	Overweight ➝ Neutral
x (Ad) In 1929, the Dow fell 89 percent and took 25 years to recover. A 60-year-old who held on wasn't whole again until age 85. In 2008, one bad year wiped out more than half the savings of those aged 56 to 65. Today, the national debt stands at 38.86 trillion dollars, far higher than in 1929. See where your retirement stands with a free Retirement Protection Kit. Get your free Retirement Protection Kit before November 3
EWBC East West Bancorp	Target Raised by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Jared Shaw Subscribe to MarketBeat All Access to unlock analyst rankings	$134.05 +0.7%	$155.00 ➝ $160.00	Overweight
FDX FedEx	Target Set by	Raymond James Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Patrick Tyler Subscribe to MarketBeat All Access to unlock analyst rankings	$319.95 +0.5%	$162.00
FHI Federated Hermes	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access to unlock brokerage rankings	Kenneth S. Lee Subscribe to MarketBeat All Access to unlock analyst rankings	$63.22 +1.1%	$60.00 ➝ $63.00	Sector Perform
FIGS FIGS	Target Raised by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Adrienne Yih Subscribe to MarketBeat All Access to unlock analyst rankings	$21.02 -1.3%	$20.00 ➝ $24.00	Overweight
FLG Flagstar Bank, National Association	Target Lowered by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Jared Shaw Subscribe to MarketBeat All Access to unlock analyst rankings	$10.69 -0.6%	$14.00 ➝ $13.00	Overweight
FMX Fomento Economico Mexicano	Target Raised by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Benjamin Theurer Subscribe to MarketBeat All Access to unlock analyst rankings	$128.82 +1.3%	$138.00 ➝ $140.00	Equal Weight
FN Fabrinet	Target Lowered by	Rosenblatt Securities Subscribe to MarketBeat All Access to unlock brokerage rankings	Mike Genovese Subscribe to MarketBeat All Access to unlock analyst rankings	$367.45 +16.8%	$750.00 ➝ $600.00	Buy
FN Fabrinet	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	Ryan Koontz Subscribe to MarketBeat All Access to unlock analyst rankings	$367.45 +16.8%	$500.00	Buy
FRAN Franchise Brands	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access to unlock brokerage rankings		GBX 160.45 +2.7%	GBX 185	Buy
FRST Primis Financial	Target Lowered by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access to unlock brokerage rankings	Woody Lay Subscribe to MarketBeat All Access to unlock analyst rankings	$14.89 -0.7%	$18.00 ➝ $17.00	Outperform
FTI TechnipFMC	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access to unlock brokerage rankings	Derek Podhaizer Subscribe to MarketBeat All Access to unlock analyst rankings	$68.20 +2.0%	$85.00 ➝ $88.00	Overweight
GEV GE Vernova	Target Lowered by	Argus Subscribe to MarketBeat All Access to unlock brokerage rankings	John Eade Subscribe to MarketBeat All Access to unlock analyst rankings	$920.05 +6.7%	$1,300.00 ➝ $1,100.00	Buy
GFUZ General Fusion Group	Initiated by	Wedbush Subscribe to MarketBeat All Access to unlock brokerage rankings	Seth Basham Subscribe to MarketBeat All Access to unlock analyst rankings	$5.98 -1.8%	$7.00	Neutral
GIL Gildan Activewear	Reiterated by	Scotiabank Subscribe to MarketBeat All Access to unlock brokerage rankings	John Zamparo Subscribe to MarketBeat All Access to unlock analyst rankings	$41.23 +0.7%	$53.00	Sector Outperform
GSK GSK	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access to unlock brokerage rankings		GBX 1,841 +0.9%	GBX 2,200	Buy
HIPO Hippo	Target Raised by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access to unlock brokerage rankings	Thomas McJoynt-Griffith Subscribe to MarketBeat All Access to unlock analyst rankings	$35.43 -0.8%	$35.00 ➝ $37.00	Market Perform
HLIT Harmonic	Target Lowered by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Tim Long Subscribe to MarketBeat All Access to unlock analyst rankings	$10.66 +4.6%	$16.00 ➝ $14.00	Equal Weight
HNGE Hinge Health	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access to unlock brokerage rankings	David Grossman Subscribe to MarketBeat All Access to unlock analyst rankings	$115.37 -0.1%	$130.00 ➝ $135.00	Buy
HNGE Hinge Health	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Richard Close Subscribe to MarketBeat All Access to unlock analyst rankings	$115.37 -0.1%	$105.00 ➝ $134.00	Buy
HNGE Hinge Health	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access to unlock brokerage rankings	Rishi Jaluria Subscribe to MarketBeat All Access to unlock analyst rankings	$115.37 -0.1%	$110.00 ➝ $135.00	Outperform
HNGE Hinge Health	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access to unlock brokerage rankings	Stan Berenshteyn Subscribe to MarketBeat All Access to unlock analyst rankings	$115.37 -0.1%	$103.00 ➝ $132.00	Overweight
HNGE Hinge Health	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	Ryan MacDonald Subscribe to MarketBeat All Access to unlock analyst rankings	$115.37 -0.1%	$115.00 ➝ $135.00	Buy
HSX Hiscox	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access to unlock brokerage rankings		GBX 1,928 +2.4%	GBX 1,148	Underperform
HWM Howmet Aerospace	Upgraded by	KeyCorp Subscribe to MarketBeat All Access to unlock brokerage rankings	Samuel McKinney Subscribe to MarketBeat All Access to unlock analyst rankings	$223.06 +4.7%	$237.00	Sector Weight ➝ Overweight
IBST Ibstock	Target Lowered by	Berenberg Bank Subscribe to MarketBeat All Access to unlock brokerage rankings		GBX 73 +0.6%	GBX 90 ➝ GBX 75	Hold
IBST Ibstock	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access to unlock brokerage rankings		GBX 73 +0.6%	GBX 90	Hold
IBTA Ibotta	Target Set by	Wells Fargo & Company Subscribe to MarketBeat All Access to unlock brokerage rankings	Ken Gawrelski Subscribe to MarketBeat All Access to unlock analyst rankings	$65.64 +31.1%	$49.00
IBTA Ibotta	Target Set by	Evercore Subscribe to MarketBeat All Access to unlock brokerage rankings	Mark Mahaney Subscribe to MarketBeat All Access to unlock analyst rankings	$65.64 +31.1%	$58.00
IBTA Ibotta	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	Bernie McTernan Subscribe to MarketBeat All Access to unlock analyst rankings	$65.64 +31.1%	$45.00 ➝ $65.00	Buy
IBTA Ibotta	Upgraded by	The Goldman Sachs Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Eric Sheridan Subscribe to MarketBeat All Access to unlock analyst rankings	$65.64 +31.1%	$58.00	Sell ➝ Neutral
ICHR Ichor	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	Charles Shi Subscribe to MarketBeat All Access to unlock analyst rankings	$36.88 +0.1%	$88.00 ➝ $55.00	Buy
ICHR Ichor	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access to unlock brokerage rankings	Brian Chin Subscribe to MarketBeat All Access to unlock analyst rankings	$36.88 +0.1%	$115.00 ➝ $93.00	Buy
IDA IDACORP	Target Raised by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Michael Lonegan Subscribe to MarketBeat All Access to unlock analyst rankings	$146.93 -0.1%	$149.00 ➝ $163.00	Overweight
IDXX IDEXX Laboratories	Reiterated by	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Andrea Alfonso Subscribe to MarketBeat All Access to unlock analyst rankings	$670.26 -0.2%	$700.00	Neutral
IMSR Terrestrial Energy	Initiated by	Wedbush Subscribe to MarketBeat All Access to unlock brokerage rankings	Seth Basham Subscribe to MarketBeat All Access to unlock analyst rankings	$2.96 -1.2%	$4.00	Neutral
INDB Independent Bank	Target Raised by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Jared Shaw Subscribe to MarketBeat All Access to unlock analyst rankings	$84.96 +0.1%	$82.00 ➝ $86.00	Underweight
INSP Inspire Medical Systems	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access to unlock brokerage rankings	Adam Maeder Subscribe to MarketBeat All Access to unlock analyst rankings	$63.09 -6.1%	$60.00 ➝ $70.00	Neutral
INSP Inspire Medical Systems	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access to unlock brokerage rankings	Mike Polark Subscribe to MarketBeat All Access to unlock analyst rankings	$63.09 -6.1%	$73.00 ➝ $77.00	Neutral
INSP Inspire Medical Systems	Target Lowered by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Christopher Pasquale Subscribe to MarketBeat All Access to unlock analyst rankings	$63.09 -6.1%	$65.00 ➝ $62.00	Underweight
INSP Inspire Medical Systems	Target Set by	Wells Fargo & Company Subscribe to MarketBeat All Access to unlock brokerage rankings	Lawrence Biegelsen Subscribe to MarketBeat All Access to unlock analyst rankings	$63.09 -6.1%	$69.00
INSP Inspire Medical Systems	Target Set by	Truist Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Richard Newitter Subscribe to MarketBeat All Access to unlock analyst rankings	$63.09 -6.1%	$76.00
IWG IWG	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access to unlock brokerage rankings		GBX 212.40 +7.7%	GBX 350	Buy
IWG IWG	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access to unlock brokerage rankings		GBX 212.40 +7.7%	GBX 235	Buy
JAZZ Jazz Pharmaceuticals	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access to unlock brokerage rankings	Leonid Timashev Subscribe to MarketBeat All Access to unlock analyst rankings	$233.52 +8.9%	$296.00 ➝ $305.00	Outperform
JAZZ Jazz Pharmaceuticals	Target Raised by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Etzer Darout Subscribe to MarketBeat All Access to unlock analyst rankings	$233.52 +8.9%	$271.00 ➝ $275.00	Overweight
JMKE Jersey Mike's	Target Lowered by	Guggenheim Subscribe to MarketBeat All Access to unlock brokerage rankings	Gregory Francfort Subscribe to MarketBeat All Access to unlock analyst rankings	$19.49 +3.6%	$29.00 ➝ $28.00	Buy
JSE Jadestone Energy	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access to unlock brokerage rankings		GBX 38.23 -2.2%	GBX 75	Buy
KOF Coca Cola FEMSA	Target Raised by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Benjamin Theurer Subscribe to MarketBeat All Access to unlock analyst rankings	$117.81 +0.6%	$122.00 ➝ $125.00	Equal Weight
KOF Coca Cola FEMSA	Downgraded by	Itau BBA Securities Subscribe to MarketBeat All Access to unlock brokerage rankings	Alejandro Fuchs Subscribe to MarketBeat All Access to unlock analyst rankings	$117.81 +0.6%	$116.00	Outperform ➝ Market Perform
KREF KKR Real Estate Finance Trust	Target Lowered by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access to unlock brokerage rankings	Jade Rahmani Subscribe to MarketBeat All Access to unlock analyst rankings	$5.17 -1.6%	$6.50 ➝ $5.50	Market Perform
x (Ad) In 1929, the Dow fell 89 percent and took 25 years to recover. A 60-year-old who held on wasn't whole again until age 85. In 2008, one bad year wiped out more than half the savings of those aged 56 to 65. Today, the national debt stands at 38.86 trillion dollars, far higher than in 1929. See where your retirement stands with a free Retirement Protection Kit. Get your free Retirement Protection Kit before November 3
KRYS Krystal Biotech	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access to unlock brokerage rankings	Lisa Walter Subscribe to MarketBeat All Access to unlock analyst rankings	$302.25 +2.1%	$400.00 ➝ $375.00	Outperform
LASR nLight	Initiated by	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	James Ricchiuti Subscribe to MarketBeat All Access to unlock analyst rankings	$37.55 +5.0%	$90.00 ➝ $50.00	Buy
LHX L3Harris Technologies	Target Raised by	Bank of America Subscribe to MarketBeat All Access to unlock brokerage rankings	Ronald Epstein Subscribe to MarketBeat All Access to unlock analyst rankings	$279.96 +0.4%	$325.00 ➝ $375.00	Buy
LIFE Ethos Technologies Inc. Class A Common Stock	Reiterated by	Citigroup Subscribe to MarketBeat All Access to unlock brokerage rankings	Ronald Josey Subscribe to MarketBeat All Access to unlock analyst rankings	$44.34 +4.0%		Market Outperform
LIFE Ethos Technologies Inc. Class A Common Stock	Target Set by	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings		$44.34 +4.0%	$55.00
LIFE Ethos Technologies Inc. Class A Common Stock	Target Raised by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Ross Sandler Subscribe to MarketBeat All Access to unlock analyst rankings	$44.34 +4.0%	$37.00 ➝ $44.00	Overweight
LIFE Ethos Technologies Inc. Class A Common Stock	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access to unlock brokerage rankings	Colin Sebastian Subscribe to MarketBeat All Access to unlock analyst rankings	$44.34 +4.0%	$32.00 ➝ $55.00	Outperform
LIFE Ethos Technologies Inc. Class A Common Stock	Target Raised by	Citizens Jmp Subscribe to MarketBeat All Access to unlock brokerage rankings	Matthew J. Carletti Subscribe to MarketBeat All Access to unlock analyst rankings	$44.34 +4.0%	$40.00 ➝ $55.00	Market Outperform
LITE Lumentum	Downgraded by	B. Riley Financial Subscribe to MarketBeat All Access to unlock brokerage rankings		$684.43 +0.0%	$770.00	Buy ➝ Neutral
LITE Lumentum	Target Lowered by	Rosenblatt Securities Subscribe to MarketBeat All Access to unlock brokerage rankings	Mike Genovese Subscribe to MarketBeat All Access to unlock analyst rankings	$684.43 +0.0%	$1,300.00 ➝ $900.00	Buy
LITE Lumentum	Target Lowered by	Susquehanna Subscribe to MarketBeat All Access to unlock brokerage rankings	Christopher Rolland Subscribe to MarketBeat All Access to unlock analyst rankings	$684.43 +0.0%	$1,100.00 ➝ $950.00	Positive
LITE Lumentum	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	Alex Henderson Subscribe to MarketBeat All Access to unlock analyst rankings	$684.43 +0.0%	$1,040.00 ➝ $800.00	Buy
LSCC Lattice Semiconductor	Target Set by	Robert W. Baird Subscribe to MarketBeat All Access to unlock brokerage rankings	Tristan Gerra Subscribe to MarketBeat All Access to unlock analyst rankings	$108.05 +13.2%	$195.00
LSCC Lattice Semiconductor	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access to unlock brokerage rankings	Ruben Roy Subscribe to MarketBeat All Access to unlock analyst rankings	$108.05 +13.2%	$165.00 ➝ $175.00	Buy
LSCC Lattice Semiconductor	Target Raised by	Rosenblatt Securities Subscribe to MarketBeat All Access to unlock brokerage rankings	Kevin Cassidy Subscribe to MarketBeat All Access to unlock analyst rankings	$108.05 +13.2%	$175.00 ➝ $200.00	Buy
LYEL Lyell Immunopharma	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	Gil Blum Subscribe to MarketBeat All Access to unlock analyst rankings	$11.36 +4.4%	$44.00	Buy
MAN ManpowerGroup	Downgraded by	BNP Paribas Exane Subscribe to MarketBeat All Access to unlock brokerage rankings		$45.84 -3.7%	$52.50	Outperform ➝ Neutral
MAR Marriott International	Target Raised by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Brandt Montour Subscribe to MarketBeat All Access to unlock analyst rankings	$419.58 +0.8%	$363.00 ➝ $409.00	Equal Weight
MAR Marriott International	Target Set by	Wells Fargo & Company Subscribe to MarketBeat All Access to unlock brokerage rankings	Trey Bowers Subscribe to MarketBeat All Access to unlock analyst rankings	$419.58 +0.8%	$426.00 ➝ $463.00	Overweight
MAR Marriott International	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access to unlock brokerage rankings	Michael Bellisario Subscribe to MarketBeat All Access to unlock analyst rankings	$419.58 +0.8%	$395.00 ➝ $414.00	Neutral
MCHB Mechanics Bancorp	Target Lowered by	Cantor Fitzgerald Subscribe to MarketBeat All Access to unlock brokerage rankings	Dave Rochester Subscribe to MarketBeat All Access to unlock analyst rankings	$14.94 -0.8%	$17.00 ➝ $16.00	Overweight
MG Mistras Group	Downgraded by	Roth Capital Subscribe to MarketBeat All Access to unlock brokerage rankings		$20.17 +0.1%	$20.35	Buy ➝ Neutral
MNDY monday.com	Reiterated by	Guggenheim Subscribe to MarketBeat All Access to unlock brokerage rankings	Howard Ma Subscribe to MarketBeat All Access to unlock analyst rankings	$92.68 -2.7%	$130.00	Buy
MNDY monday.com	Downgraded by	TD Cowen Subscribe to MarketBeat All Access to unlock brokerage rankings	Derrick Wood Subscribe to MarketBeat All Access to unlock analyst rankings	$92.68 -2.7%	$110.00 ➝ $105.00	Buy ➝ Hold
MNDY monday.com	Target Set by	Morgan Stanley Subscribe to MarketBeat All Access to unlock brokerage rankings		$92.68 -2.7%	$105.00
MNTN MNTN	Initiated by	Freedom Broker Subscribe to MarketBeat All Access to unlock brokerage rankings	Saken Ismailov Subscribe to MarketBeat All Access to unlock analyst rankings	$9.62 +2.2%	$16.50	Buy
MPT Medical Properties Trust	Downgraded by	BNP Paribas Exane Subscribe to MarketBeat All Access to unlock brokerage rankings		$2.06 -5.5%	$2.25	Outperform ➝ Neutral
MRBK Meridian	Downgraded by	DA Davidson Subscribe to MarketBeat All Access to unlock brokerage rankings	Peter Winter Subscribe to MarketBeat All Access to unlock analyst rankings	$17.69 -4.7%	$22.00 ➝ $20.00	Buy ➝ Neutral
MRK Merck & Co., Inc.	Downgraded by	DZ Bank Subscribe to MarketBeat All Access to unlock brokerage rankings		$145.70 -1.8%	$153.00	Buy ➝ Hold
MRSH Marsh & McLennan Companies	Upgraded by	BMO Capital Markets Subscribe to MarketBeat All Access to unlock brokerage rankings	Michael Zaremski Subscribe to MarketBeat All Access to unlock analyst rankings	$205.16 -0.1%	$204.00 ➝ $230.00	Market Perform ➝ Outperform
MRVL Marvell Technology	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access to unlock brokerage rankings	Srini Pajjuir Subscribe to MarketBeat All Access to unlock analyst rankings	$171.39 0.0%	$425.00 ➝ $250.00	Outperform
MRVL Marvell Technology	Downgraded by	Bank of America Subscribe to MarketBeat All Access to unlock brokerage rankings	Vivek Arya Subscribe to MarketBeat All Access to unlock analyst rankings	$171.39 0.0%	$400.00 ➝ $225.00	Buy ➝ Neutral
MRVL Marvell Technology	Downgraded by	TD Cowen Subscribe to MarketBeat All Access to unlock brokerage rankings	Sean O'Loughlin Subscribe to MarketBeat All Access to unlock analyst rankings	$171.39 0.0%	$350.00 ➝ $175.00	Buy ➝ Hold
MRVL Marvell Technology	Target Lowered by	Cantor Fitzgerald Subscribe to MarketBeat All Access to unlock brokerage rankings	C.J. Muse Subscribe to MarketBeat All Access to unlock analyst rankings	$171.39 0.0%	$350.00 ➝ $225.00	Neutral
MRVL Marvell Technology	Target Lowered by	Susquehanna Subscribe to MarketBeat All Access to unlock brokerage rankings	Christopher Rolland Subscribe to MarketBeat All Access to unlock analyst rankings	$171.39 0.0%	$340.00 ➝ $300.00	Positive
MRVL Marvell Technology	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	N. Quinn Bolton Subscribe to MarketBeat All Access to unlock analyst rankings	$171.39 0.0%	$400.00 ➝ $300.00	Buy
MTCH Match Group	Upgraded by	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings		$39.65 -5.7%		Buy
MTCH Match Group	Target Raised by	Susquehanna Subscribe to MarketBeat All Access to unlock brokerage rankings	Shyam Patil Subscribe to MarketBeat All Access to unlock analyst rankings	$39.65 -5.7%	$45.00 ➝ $50.00	Positive
MTCH Match Group	Reiterated by	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings		$39.65 -5.7%		Neutral
MTCH Match Group	Target Raised by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Ross Sandler Subscribe to MarketBeat All Access to unlock analyst rankings	$39.65 -5.7%	$51.00 ➝ $52.00	Overweight
NBIX Neurocrine Biosciences	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access to unlock brokerage rankings	Brian Abrahams Subscribe to MarketBeat All Access to unlock analyst rankings	$164.68 +13.3%	$187.00 ➝ $190.00	Outperform
NBIX Neurocrine Biosciences	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access to unlock brokerage rankings	David Amsellem Subscribe to MarketBeat All Access to unlock analyst rankings	$164.68 +13.3%	$210.00 ➝ $215.00	Overweight
NBIX Neurocrine Biosciences	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Sumant Kulkarni Subscribe to MarketBeat All Access to unlock analyst rankings	$164.68 +13.3%	$210.00 ➝ $220.00	Buy
NBR Nabors Industries	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access to unlock brokerage rankings	Derek Podhaizer Subscribe to MarketBeat All Access to unlock analyst rankings	$83.55 -1.3%	$130.00 ➝ $145.00	Overweight
NET Cloudflare	Upgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access to unlock brokerage rankings	Samik Chatterjee Subscribe to MarketBeat All Access to unlock analyst rankings	$276.07 +4.1%	$350.00	Neutral ➝ Overweight
NOW ServiceNow	Reiterated by	Argus Subscribe to MarketBeat All Access to unlock brokerage rankings	Joseph Bonner Subscribe to MarketBeat All Access to unlock analyst rankings	$107.83 +1.7%	$170.00	Buy
NXT Nextpower	Target Raised by	Glj Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Gordon L. Johnson Subscribe to MarketBeat All Access to unlock analyst rankings	$97.62 +7.1%	$149.00 ➝ $158.00	Buy
O Realty Income	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access to unlock brokerage rankings	Brad Heffern Subscribe to MarketBeat All Access to unlock analyst rankings	$57.25 -0.6%	$60.00 ➝ $61.00	Outperform
OFRM Once Upon A Farm	Downgraded by	Bank of America Subscribe to MarketBeat All Access to unlock brokerage rankings	Peter Galbo Subscribe to MarketBeat All Access to unlock analyst rankings	$9.25 -2.1%	$21.00 ➝ $10.00	Buy ➝ Underperform
OKLO Oklo	Initiated by	Wedbush Subscribe to MarketBeat All Access to unlock brokerage rankings		$23.67 +0.7%	$36.00	Outperform
U.S. Army Advances 75-Year Rare Earth Deal With Nasdaq Firm (Ad) The Pentagon is moving to cut US dependence on Chinese rare earth metals, and a Nasdaq-listed company just signed a term sheet for a potential 75-year agreement with the US Army. The proposed deal would let the company build and operate a rare earth processing facility on an active military base, with the Army getting first right to production. New Pentagon restrictions on Chinese-origin rare earth magnets take effect January 1, 2027. The company's mine-to-magnet platform covers feedstock agreements, processing, metallization, and downstream manufacturing, with commercial output targeted for 2027. Read the full breakdown on this rare earth opportunity now
ON onsemi	Upgraded by	Craig Hallum Subscribe to MarketBeat All Access to unlock brokerage rankings		$73.08 +4.2%	$85.00	Hold ➝ Buy
ON onsemi	Target Lowered by	Rosenblatt Securities Subscribe to MarketBeat All Access to unlock brokerage rankings	Kevin Cassidy Subscribe to MarketBeat All Access to unlock analyst rankings	$73.08 +4.2%	$85.00 ➝ $80.00	Neutral
ON onsemi	Reiterated by	Cantor Fitzgerald Subscribe to MarketBeat All Access to unlock brokerage rankings	Matthew Prisco Subscribe to MarketBeat All Access to unlock analyst rankings	$73.08 +4.2%	$90.00	Neutral
ON onsemi	Reiterated by	Wells Fargo & Company Subscribe to MarketBeat All Access to unlock brokerage rankings	Joe Quatrochi Subscribe to MarketBeat All Access to unlock analyst rankings	$73.08 +4.2%	$90.00	Overweight
ON onsemi	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	N. Quinn Bolton Subscribe to MarketBeat All Access to unlock analyst rankings	$73.08 +4.2%	$116.00	Buy
ONON ON	Reiterated by	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Janine Stichter Subscribe to MarketBeat All Access to unlock analyst rankings	$36.34 +2.3%	$60.00	Buy
ONON ON	Upgraded by	Cantor Fitzgerald Subscribe to MarketBeat All Access to unlock brokerage rankings		$36.34 +2.3%		Buy
OPY Oppenheimer	Upgraded by	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings		$89.09 +6.4%		Outperform
PAG Penske Automotive Group	Target Raised by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	John Babcock Subscribe to MarketBeat All Access to unlock analyst rankings	$213.45 +0.1%	$210.00 ➝ $212.00	Overweight
PDS Precision Drilling	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access to unlock brokerage rankings	Derek Podhaizer Subscribe to MarketBeat All Access to unlock analyst rankings	$98.82 +1.2%	$105.00 ➝ $115.00	Overweight
PIPR Piper Sandler Companies	Reiterated by	Bank of America Subscribe to MarketBeat All Access to unlock brokerage rankings		$66.98 -0.7%	$69.00	Underperform
PLTR Palantir Technologies	Target Raised by	Morgan Stanley Subscribe to MarketBeat All Access to unlock brokerage rankings	Sanjit Singh Subscribe to MarketBeat All Access to unlock analyst rankings	$171.23 -4.0%	$205.00 ➝ $233.00	Cautious ➝ Buy
PLTR Palantir Technologies	Reiterated by	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Karl Keirstead Subscribe to MarketBeat All Access to unlock analyst rankings	$171.23 -4.0%		Buy
PLTR Palantir Technologies	Reiterated by	Piper Sandler Subscribe to MarketBeat All Access to unlock brokerage rankings	Clark Jeffries Subscribe to MarketBeat All Access to unlock analyst rankings	$171.23 -4.0%	$231.00 ➝ $235.00	Overweight
PLTR Palantir Technologies	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access to unlock brokerage rankings	Rishi Jaluria Subscribe to MarketBeat All Access to unlock analyst rankings	$171.23 -4.0%	$90.00 ➝ $130.00	Underperform
PLTR Palantir Technologies	Target Set by	Truist Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Arvind Ramnani Subscribe to MarketBeat All Access to unlock analyst rankings	$171.23 -4.0%	$250.00
PLTR Palantir Technologies	Reiterated by	Rosenblatt Securities Subscribe to MarketBeat All Access to unlock brokerage rankings	John McPeake Subscribe to MarketBeat All Access to unlock analyst rankings	$171.23 -4.0%	$260.00	Buy
PLTR Palantir Technologies	Reiterated by	DA Davidson Subscribe to MarketBeat All Access to unlock brokerage rankings	Gil Luria Subscribe to MarketBeat All Access to unlock analyst rankings	$171.23 -4.0%	$250.00	Buy
PM Philip Morris International	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access to unlock brokerage rankings	Matthew Smith Subscribe to MarketBeat All Access to unlock analyst rankings	$207.38 -0.4%	$205.00 ➝ $232.00	Buy
PONY Pony AI	Initiated by	Morgan Stanley Subscribe to MarketBeat All Access to unlock brokerage rankings	Tim Hsiao Subscribe to MarketBeat All Access to unlock analyst rankings	$4.59 -0.8%	$10.00	Overweight
PTEN Patterson-UTI Energy	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access to unlock brokerage rankings	Derek Podhaizer Subscribe to MarketBeat All Access to unlock analyst rankings	$11.84 +0.3%	$14.00 ➝ $15.00	Overweight
PTGX Protagonist Therapeutics	Reiterated by	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Alice Nettleton Subscribe to MarketBeat All Access to unlock analyst rankings	$143.87 +3.2%		Buy
PUSA Powerus	Initiated by	Northland Securities Subscribe to MarketBeat All Access to unlock brokerage rankings		$1.70 +5.0%	$5.00	Outperform
ROKU Roku	Downgraded by	Rosenblatt Securities Subscribe to MarketBeat All Access to unlock brokerage rankings	Barton Crockett Subscribe to MarketBeat All Access to unlock analyst rankings	$160.24 +3.0%	$160.00	Buy ➝ Neutral
ROKU Roku	Upgraded by	BMO Capital Markets Subscribe to MarketBeat All Access to unlock brokerage rankings		$160.24 +3.0%		Market Perform ➝ Outperform
ROKU Roku	Reiterated by	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	Laura Martin Subscribe to MarketBeat All Access to unlock analyst rankings	$160.24 +3.0%		Buy
SBAC SBA Communications	Reiterated by	Citigroup Subscribe to MarketBeat All Access to unlock brokerage rankings		$182.70 -1.2%		Market Outperform
SBAC SBA Communications	Target Set by	Wells Fargo & Company Subscribe to MarketBeat All Access to unlock brokerage rankings	Eric Luebchow Subscribe to MarketBeat All Access to unlock analyst rankings	$182.70 -1.2%	$200.00
SBUX Starbucks	Initiated by	Stephens Subscribe to MarketBeat All Access to unlock brokerage rankings		$104.14 -0.3%	$39.00	Equal Weight
SIBN SiBone	Reiterated by	Citigroup Subscribe to MarketBeat All Access to unlock brokerage rankings		$22.49 +11.2%		Market Outperform
SIBN SiBone	Target Lowered by	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	David Saxon Subscribe to MarketBeat All Access to unlock analyst rankings	$22.49 +11.2%	$27.00 ➝ $26.00	Buy
SIRI Sirius XM	Upgraded by	The Goldman Sachs Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Brett Feldman Subscribe to MarketBeat All Access to unlock analyst rankings	$30.36 +2.7%	$37.00	Neutral ➝ Buy
SITM SiTime	Target Raised by	Rosenblatt Securities Subscribe to MarketBeat All Access to unlock brokerage rankings	Sajal Dogra Subscribe to MarketBeat All Access to unlock analyst rankings	$452.53 +8.3%	$750.00 ➝ $900.00	Buy
SMR NuScale Power	Initiated by	Wedbush Subscribe to MarketBeat All Access to unlock brokerage rankings	Seth Basham Subscribe to MarketBeat All Access to unlock analyst rankings	$5.43 +1.4%	$5.00	Underperform
SNDX Syndax Pharmaceuticals	Target Set by	Mizuho Subscribe to MarketBeat All Access to unlock brokerage rankings	Salim Syed Subscribe to MarketBeat All Access to unlock analyst rankings	$13.94 +6.4%	$43.00
SNDX Syndax Pharmaceuticals	Target Lowered by	HC Wainwright Subscribe to MarketBeat All Access to unlock brokerage rankings	Andres Y. Maldonado Subscribe to MarketBeat All Access to unlock analyst rankings	$13.94 +6.4%	$38.00 ➝ $36.00	Buy
SPWH Sportsman's Warehouse	Initiated by	LADENBURG THALM/SH SH Subscribe to MarketBeat All Access to unlock brokerage rankings	Michael Legg Subscribe to MarketBeat All Access to unlock analyst rankings	$1.11 +1.8%	$2.60	Buy
SSB SouthState Bank	Target Raised by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Jared Shaw Subscribe to MarketBeat All Access to unlock analyst rankings	$107.53 +0.5%	$120.00 ➝ $128.00	Overweight
STRT Strattec Security	Upgraded by	Freedom Broker Subscribe to MarketBeat All Access to unlock brokerage rankings	Kanagat Yertay Subscribe to MarketBeat All Access to unlock analyst rankings	$64.79 +2.0%	$83.00 ➝ $79.00	Hold ➝ Buy
STRT Strattec Security	Target Set by	Wedbush Subscribe to MarketBeat All Access to unlock brokerage rankings		$64.79 +2.0%	$79.00
SUI Sun Communities	Reiterated by	Citigroup Subscribe to MarketBeat All Access to unlock brokerage rankings		$116.45 -0.3%		Market Outperform
SUPR Supermarket Income REIT	Reiterated by	Jefferies Financial Group Subscribe to MarketBeat All Access to unlock brokerage rankings		GBX 82.80 -1.9%	GBX 90	Buy
SW Smurfit Westrock	Target Lowered by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Pallav Mittal Subscribe to MarketBeat All Access to unlock analyst rankings	$42.85 -1.3%	$56.00 ➝ $55.00	Overweight
TATT TAT Technologies	Reiterated by	UBS Group Subscribe to MarketBeat All Access to unlock brokerage rankings		$37.97 +1.5%		Buy
TBBK Bancorp	Reiterated by	Raymond James Financial Subscribe to MarketBeat All Access to unlock brokerage rankings	Steve Moss Subscribe to MarketBeat All Access to unlock analyst rankings	$45.67 -1.1%	$57.00	Outperform
TCBI Texas Capital Bancshares	Target Raised by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Jared Shaw Subscribe to MarketBeat All Access to unlock analyst rankings	$104.65 +0.5%	$100.00 ➝ $110.00	Equal Weight
TCBX Third Coast Bancshares	Target Lowered by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access to unlock brokerage rankings	Woody Lay Subscribe to MarketBeat All Access to unlock analyst rankings	$40.66 0.0%	$48.00 ➝ $46.00	Market Perform
TCMD Tactile Systems Technology	Target Lowered by	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Ryan Zimmerman Subscribe to MarketBeat All Access to unlock analyst rankings	$24.20 +5.8%	$35.00 ➝ $31.00	Buy
TEAM Atlassian	Reiterated by	TD Cowen Subscribe to MarketBeat All Access to unlock brokerage rankings	Derrick Wood Subscribe to MarketBeat All Access to unlock analyst rankings	$186.63 -0.2%		Hold
TEM Tempus AI	Target Raised by	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Mark Massaro Subscribe to MarketBeat All Access to unlock analyst rankings	$81.41 +3.7%	$80.00 ➝ $100.00	Buy
TEM Tempus AI	Upgraded by	Jefferies Financial Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Tycho Peterson Subscribe to MarketBeat All Access to unlock analyst rankings	$81.41 +3.7%	$35.00 ➝ $70.00	Underperform ➝ Hold
TEM Tempus AI	Target Raised by	HC Wainwright Subscribe to MarketBeat All Access to unlock brokerage rankings	Yi Chen Subscribe to MarketBeat All Access to unlock analyst rankings	$81.41 +3.7%	$68.00 ➝ $85.00	Buy
TEM Tempus AI	Target Raised by	Robert W. Baird Subscribe to MarketBeat All Access to unlock brokerage rankings	Catherine Schulte Subscribe to MarketBeat All Access to unlock analyst rankings	$81.41 +3.7%	$85.00 ➝ $92.00	Outperform
TEM Tempus AI	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access to unlock brokerage rankings	Sarah James Subscribe to MarketBeat All Access to unlock analyst rankings	$81.41 +3.7%	$80.00 ➝ $92.00	Overweight
THC Tenet Healthcare	Target Raised by	KeyCorp Subscribe to MarketBeat All Access to unlock brokerage rankings	Matthew Gillmor Subscribe to MarketBeat All Access to unlock analyst rankings	$273.07 +1.6%	$270.00 ➝ $300.00	Overweight
TOWN Towne Bank	Target Raised by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access to unlock brokerage rankings	Catherine Mealor Subscribe to MarketBeat All Access to unlock analyst rankings	$37.04 -0.2%	$38.00 ➝ $39.00	Market Perform
TSEM Tower Semiconductor	Target Lowered by	Stifel Nicolaus Subscribe to MarketBeat All Access to unlock brokerage rankings	Sahej Singh Subscribe to MarketBeat All Access to unlock analyst rankings	$162.02 +4.3%	$270.00 ➝ $235.00	Buy
TSEM Tower Semiconductor	Target Lowered by	Susquehanna Subscribe to MarketBeat All Access to unlock brokerage rankings	Medhi Hosseini Subscribe to MarketBeat All Access to unlock analyst rankings	$162.02 +4.3%	$355.00 ➝ $305.00	Positive
TSEM Tower Semiconductor	Reiterated by	Wedbush Subscribe to MarketBeat All Access to unlock brokerage rankings	Matt Bryson Subscribe to MarketBeat All Access to unlock analyst rankings	$162.02 +4.3%	$190.00	Neutral
TUNE Focusrite	Reiterated by	Berenberg Bank Subscribe to MarketBeat All Access to unlock brokerage rankings		GBX 232.80 +6.3%	GBX 355	Buy
TWLO Twilio	Upgraded by	HSBC Subscribe to MarketBeat All Access to unlock brokerage rankings	Stephen Bersey Subscribe to MarketBeat All Access to unlock analyst rankings	$216.36 +4.2%	$211.00 ➝ $215.00	Reduce ➝ Hold
TXT Textron	Reiterated by	Bank of America Subscribe to MarketBeat All Access to unlock brokerage rankings		$88.40 -0.1%	$100.00	Neutral
UMBF UMB Financial	Target Raised by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Jared Shaw Subscribe to MarketBeat All Access to unlock analyst rankings	$137.59 +0.1%	$175.00 ➝ $185.00	Overweight
UPWK Upwork	Reiterated by	Royal Bank Of Canada Subscribe to MarketBeat All Access to unlock brokerage rankings	Brad Erickson Subscribe to MarketBeat All Access to unlock analyst rankings	$10.14 +4.3%	$8.00	Sector Perform
UPWK Upwork	Reiterated by	BTIG Research Subscribe to MarketBeat All Access to unlock brokerage rankings	Marvin Fong Subscribe to MarketBeat All Access to unlock analyst rankings	$10.14 +4.3%		Neutral
UPWK Upwork	Target Raised by	Scotiabank Subscribe to MarketBeat All Access to unlock brokerage rankings	Nat Schindler Subscribe to MarketBeat All Access to unlock analyst rankings	$10.14 +4.3%	$8.00 ➝ $10.00	Sector Perform
UPWK Upwork	Target Raised by	Needham & Company LLC Subscribe to MarketBeat All Access to unlock brokerage rankings	Bernie McTernan Subscribe to MarketBeat All Access to unlock analyst rankings	$10.14 +4.3%	$11.00 ➝ $13.00	Buy
VLY Valley National Bancorp	Target Raised by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Jared Shaw Subscribe to MarketBeat All Access to unlock analyst rankings	$14.50 +0.3%	$15.00 ➝ $17.00	Equal Weight
VNOM Viper Energy	Downgraded by	Oppenheimer Subscribe to MarketBeat All Access to unlock brokerage rankings		$45.42 -0.7%	$53.00	Outperform ➝ Market Perform
VRRM Verra Mobility	Downgraded by	JPMorgan Chase & Co. Subscribe to MarketBeat All Access to unlock brokerage rankings	Tomohiko Sano Subscribe to MarketBeat All Access to unlock analyst rankings	$2.66 -0.9%		Neutral ➝ Underweight
VRTX Vertex Pharmaceuticals	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access to unlock brokerage rankings	Mohit Bansal Subscribe to MarketBeat All Access to unlock analyst rankings	$537.85 -2.8%	$550.00 ➝ $650.00	Overweight
VRTX Vertex Pharmaceuticals	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access to unlock brokerage rankings	Brian Abrahams Subscribe to MarketBeat All Access to unlock analyst rankings	$537.85 -2.8%	$576.00 ➝ $600.00	Outperform
VRTX Vertex Pharmaceuticals	Target Raised by	Cantor Fitzgerald Subscribe to MarketBeat All Access to unlock brokerage rankings	Carter Gould Subscribe to MarketBeat All Access to unlock analyst rankings	$537.85 -2.8%	$595.00 ➝ $619.00	Overweight
VRTX Vertex Pharmaceuticals	Target Raised by	Stifel Nicolaus Subscribe to MarketBeat All Access to unlock brokerage rankings	Paul Matteis Subscribe to MarketBeat All Access to unlock analyst rankings	$537.85 -2.8%	$500.00 ➝ $563.00	Hold
VSXY Victoria's Secret & Co.	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access to unlock brokerage rankings	Ike Boruchow Subscribe to MarketBeat All Access to unlock analyst rankings	$99.83 +1.3%	$100.00 ➝ $120.00	Overweight
VVX V2X	Target Raised by	Royal Bank Of Canada Subscribe to MarketBeat All Access to unlock brokerage rankings	Ken Herbert Subscribe to MarketBeat All Access to unlock analyst rankings	$82.03 -1.4%	$81.00 ➝ $88.00	Sector Perform
WAL Western Alliance Bancorporation	Target Raised by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Jared Shaw Subscribe to MarketBeat All Access to unlock analyst rankings	$78.62 -0.1%	$93.00 ➝ $95.00	Overweight
WAY Waystar	Target Raised by	Canaccord Genuity Group Subscribe to MarketBeat All Access to unlock brokerage rankings	Richard Close Subscribe to MarketBeat All Access to unlock analyst rankings	$27.01 -4.0%	$33.00 ➝ $34.00	Buy
WD Walker & Dunlop	Target Lowered by	Keefe, Bruyette & Woods Subscribe to MarketBeat All Access to unlock brokerage rankings	Jade Rahmani Subscribe to MarketBeat All Access to unlock analyst rankings	$35.60 -0.4%	$45.00 ➝ $43.00	Outperform
WHD Cactus	Target Raised by	Piper Sandler Subscribe to MarketBeat All Access to unlock brokerage rankings	Derek Podhaizer Subscribe to MarketBeat All Access to unlock analyst rankings	$62.64 +0.7%	$75.00 ➝ $78.00	Overweight
WLTH Wealthfront	Target Raised by	Wells Fargo & Company Subscribe to MarketBeat All Access to unlock brokerage rankings	Daniel Welden Subscribe to MarketBeat All Access to unlock analyst rankings	$10.49 +0.5%	$11.50 ➝ $12.00	Overweight
WTFC Wintrust Financial	Target Raised by	Barclays Subscribe to MarketBeat All Access to unlock brokerage rankings	Jared Shaw Subscribe to MarketBeat All Access to unlock analyst rankings	$157.94 +0.3%	$190.00 ➝ $195.00	Overweight
XE X-Energy	Initiated by	Wedbush Subscribe to MarketBeat All Access to unlock brokerage rankings	Seth Basham Subscribe to MarketBeat All Access to unlock analyst rankings	$11.15 +7.5%	$17.00	Outperform
ZG Zillow Group	Target Lowered by	Royal Bank Of Canada Subscribe to MarketBeat All Access to unlock brokerage rankings	Brad Erickson Subscribe to MarketBeat All Access to unlock analyst rankings	$31.93 -2.9%	$55.00 ➝ $45.00	Outperform
ZG Zillow Group	Target Lowered by	KeyCorp Subscribe to MarketBeat All Access to unlock brokerage rankings	Sergio Segura Subscribe to MarketBeat All Access to unlock analyst rankings	$31.93 -2.9%	$48.00 ➝ $42.00	Overweight

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 10:43 AM ET.

Stock Ratings and Recommendations: Understanding Analyst Ratings

Written by MarketBeat Staff

Key Points

Stock analysts give ratings to companies based on their research and insights.
Analysis comes from the buy side (fund companies, investment managers) or sell side (brokers, banks).
Analysts use different methodologies, so investors should always look into why a particular rating was given.
5 stocks we like better than EXA)

You'll often hear a particular stock called a "buy" or "sell," but who exactly makes these calls? Ratings and recommendations come from stock analysts, who research different securities and work for various institutions, brokerage firms and other financial companies.

Analyst ratings are designed to give additional information to investors beyond just what the company is saying, but are analyst ratings reliable? In this article, we'll discuss how to read analyst ratings, what goes into their decision-making process and how potential conflicts of interest influence analyst stock ratings.

What Are Analyst Ratings?

A stock rating is a simple heuristic given by analysts who review the firm's financial statements, listen to conference calls, chat with company executives and compare the stock to others in the industry or sector. Finally, an analyst uses all this information to produce a simple recommendation and price target.

When a public analyst goes on CNBC or the "Wall Street Journal" to give a "buy" or "sell" rating on a particular stock, they take all their research and pare it down into a simple designation. While there's no true consensus on what constitutes a buy or sell rating, an analyst usually does have "skin in the game" when devising ratings.

Ratings often pair with price targets, which put a hard number on what the analysts believe the company stock should be worth. So, for example, you might see an analyst report something like, "Buy NVIDIA Inc. (NASDAQ: NVDA), price target $350," which means that particular analyst believes investors should buy NVDA shares up to a price of $350 per share.

Analyst ratings infographic: What you need to know

What Does a Stock Analyst Do?

A stock analyst is a market professional with the skills to interpret financial data and the connections within companies to speak on the record with higher-ups. Analysts generally fall into one of two different camps: buy-side or sell-side. These positions will seem similar, but they tend to be employed by various institutions and have different responsibilities in their particular market "territories."

Buy-side analysts: Analysts on the buy side tend to work for funds, such as ETF providers or hedge funds. They don't dig as deeply into company financial data or conference calls as sell-siders. Instead, they focus on general areas or industries where their funds have vested interests. In addition, buy-side analysts often forge relationships with sell-side analysts for individual stock research. A buy-side analyst's primary goal is to find and utilize the most accurate and dependable sell-side analysts.
Sell-side analysts: If buy-side analysts work for funds (i.e., institutions that buy securities), you can probably guess which type of institution employs sell-side analysts. Brokers, banks and other firms that sell securities to investors use sell-side analysts to give reports to the public. While buy-side analysts also give ratings and price targets, the reported "buy" and "sell" ratings in financial media typically come from folks on the sell side.

Buy and sell-side analysts often use different rating systems when making their recommendations. You might even find two sell-side analysts with similar "buy" recommendations with vastly different price targets in the same stock. As a result, you'll need to familiarize yourself with the various methodologies analysts use to utilize their research correctly.

What Ratings Do Analysts Give?

Stock analyst ratings don't follow a strict structure, although most have roughly the same grading system for the securities they review. The labels may differ slightly (i.e., overweight vs. outperform), but the five most common analyst ratings go like this.

Buy

Analysts bullish on a particular security will give it a "buy" rating and set a price target above the current market price. In addition, if the analyst considers the stock one of the best in the industry or sector, you'll sometimes see a "strong buy" rating attached.

Hold

A "hold" rating is typically the lowest rating a sell-side analyst gives a stock. "Hold" means the analyst projects the stock to meet the return of the market averages, making it an unspectacular investment. Stocks rated "hold" may still have a price target above the current price, but it's not likely to surpass the return of a major index like the S&P 500.

Sell

Analysts are usually apprehensive about giving a stock a "sell" rating. For example, suppose a "hold" rating indicates indecision over the stock's future. In this scenario, a "sell" rating is issued when an analyst finds something unappealing, such as questionable accounting tactics or cratering sales growth.

Underperform

Analysts won't always give a firm "buy" or "sell" rating on stock but will instead label it "underperform" or "outperform." "Underperform" means the analyst expects the stock not to keep up with the market. It doesn't necessarily mean the analyst predicts a crash but indicates a lack of confidence in the shares.

Outperform

"Outperform" is the opposite of "underperform," meaning the analyst expects the stock to do better than the market average. It's usually considered a less confident rating than "buy."

Example of an Analyst Rating

You can use MarketBeat Analyst Ratings to find ranges and aggregates from buy- and sell-side analysts across the financial media. For example, here's a stock that analysts usually love: Alphabet Inc. (NASDAQ: GOOG).

Overview of stock analysis on GOOG Using MarketBeat's tools, you can find ratings from prominent analysts from multiple periods. Alphabet is currently labeled a "moderate buy" based on MarketBeat's consensus from 17 analysts. You'll get the consensus price target and the highest and lowest from the analysts surveyed.

Marketbeat's tools detailing analyst ratings

Looking at analyst recommendations over time is another helpful tool. For example, you can view the different levels of coverage over the last few years, which analysts changed their ratings and how the price targets vary from month to month. If an analyst can't get a good read on a particular stock they've been covering, they might choose to withhold their grade, which is one reason why the number of available ratings can change over time.

Overview of analyst ratings on MarketBeat Analysts from both sides of the aisle can be found on MarketBeat, ranging from large firms like JPMorgan Chase and Co. (NYSE: JPM) to smaller investment banks like Roth Capital. Some institutions like UBS Group offer both buy-side and sell-side ratings and analysis. These graphs show that even analysts with similar ratings can have vastly different price targets, so always understand the reasoning behind an analyst's view.

How to Use Analyst Ratings

Here are a few pointers on incorporating analyst ratings into your investment research.

Step 1: Don't rely on a single analyst.

Using an array of analysts (buy- and sell-side) gives inventors the most possible information. Don't just look for analysts with similar opinions as yourself — ensure you understand the pros and cons of each investment you make by incorporating positive and negative views, if possible.

Step 2: Compare analyst ratings across the industry or sector.

It's easy to slap a "buy" rating on a stock and predict a winner, but comparing stocks against others in the sector can offer insight into the rating. For example, if a stock is rated "buy" in the information technology sector, but a dozen others are rated "strong buy" by the same analyst, where is your capital best served?

Step 3: Consider your own goals and risk tolerance.

You might find stocks rated "strong buy" in your research in sectors you wish to avoid. That's fine! There are thousands of securities across dozens of industries in the public markets, and you don't need to purchase every share that comes with a "buy" rating. Instead, stick to your investment plan.

Step 4: Don't stubbornly stick to your original assessments.

Following your investment plan and using analyst ratings as guidelines are practical steps, but things can change over time. Today's "strong buy" stocks could be "strong sell" stocks down the road. Using an aggregate of analysts' ratings can help investors view stocks from a higher level. For example, if the number of "buy" ratings on a stock drops 40% over a few years, you might want to take a closer look at that particular company.

Why Are Analyst Ratings Important?

Checking out analyst ratings isn't a necessary step for investing, but it can be helpful for those looking to dig deep into an asset's prospects. Analyst research often has quotes from company executives, questions from conference calls and in-depth reporting on the company's balance sheet, income statement and other essential documents. Analysis like this is complex for individual investors to do on their own, especially considering how frequently analysts interact with the executives they cover. But access often comes with a downside, which we discuss more below.

How Accurate Are Analyst Ratings?

Both buy and sell-side analysts strive for accuracy because giving consistently wrong commendations can be hazardous for job security. However, investors should be aware that analysts might not always have the best interest of the retail investor at heart when making their recommendations.

For starters, being an analyst requires access to company employees and management. Analysts typically ask questions during conference calls and speak with C-suite executives on the record about their firms' prospects. Executives usually don't want to hear adverse reports about their companies, so analysts are incentivized to paint a rosy picture to retain access. The SEC has been questioning the authenticity of analyst ratings (especially on the sell-side) since 2002 when it asked bluntly, "Why are there so few sell ratings?"

Of course, there are other areas of the securities analysis market to face scrutiny. If you recall, during the 2008 financial crisis, the biggest credit rating agencies were all held to the fire due to claims that conflicts of interest influenced their ratings. The biggest rating agencies in the world were accused of "misrepresenting the risks associated with mortgage-backed securities." Remember, analyst ratings aren't spat out by computer algorithms but by living, breathing people who may have agendas other than providing the most precise and accurate reports on a company's future prospects.

Analyst Ratings Can Guide Investors, but Don't Treat Them as Gospel

Consider each type of investment research or advice in collaboration. Even the most accurate and thoughtful analysts get things wrong, plus ratings are frequently besieged with conflicts of interest. But analyst coverage does offer research that's difficult to get elsewhere, and using an array of analyst reports can give investors a deeper understanding of the securities they buy.

FAQs

Still have questions about analyst ratings? Here are a few answers to some common points of discussion:

What are analyst ratings?

Analyst ratings are the "buy" and "sell" labels, plus price targets, that investment researchers attach to specific securities. These ratings are based on financial data, earnings reports and conversations with company executives.

Should you trust analyst ratings?

Analyst ratings provide plenty of helpful information, but you shouldn't use an analyst's "buy" rating as the sole reason you purchase a security. Analysts aren't immune to conflicts of interest or outside parties' influence, so ensure you always understand why a stock was labeled a "buy" or "sell."

What does an analyst rating tell you about a stock?

Ratings give investors the analyst's overall opinion about a particular stock and price targets based on the company's valuation and prospects. Analysts often attend conference calls, ask questions and provide in-depth information about companies that are difficult to acquire elsewhere.

Stock Forecasts and Research Tools

Today's Analyst Ratings

Top-Rated Stocks

More Ratings Tools

Price Forecasts for Popular Stocks

Top Stock Recommendations by Brokerage

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Stock Price Targets and Analyst Ratings